In terms of deals, about 16% of companies acquired in 2012 had Corporate Venture Capital (CVC) and for 2013, 90% of slated IPOs include CVC.

FORBES: Corporate Venture Funds Increasingly Important To Startups

An interesting article by Vinay Singh evaluated the impact of Pharma corporate venture capital (CVC) investing, and the key takeaway is that CVC-backed companies have a higher rate of overall success than those without their involvement.

FORBES: Want Better Odds? Get a Pharma Corporate VC to Invest

However, CVC added that there was no certainty it would make a formal bid.

BBC: Betfair shares surge on CVC takeover talk